|
Oct 2
|
Top Midday Decliners
|
|
Oct 2
|
Eagle Pharmaceuticals in Default Amid Delays in Financial Report Filings, Braces for Delisting
|
|
Apr 30
|
Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Annua...
|
|
Apr 15
|
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
|
|
Apr 12
|
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
|
|
Dec 6
|
Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City
|
|
Nov 29
|
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q
|
|
Nov 29
|
Eagle Pharmaceuticals Announces Management Change
|
|
Nov 27
|
Down -33.75% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround
|
|
Nov 8
|
Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023
|
|
Nov 2
|
Canopy Growth Corporation (CGC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Aug 11
|
Is Eagle Pharmaceuticals (EGRX) Stock Undervalued Right Now?
|
|
Aug 9
|
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
|
|
Aug 8
|
Eagle Pharmaceuticals (EGRX) Tops Q2 Earnings and Revenue Estimates
|
|
Aug 8
|
Eagle Pharmaceuticals Reports Second Quarter 2023 Results
|
|
May 1
|
Eagle Pharmaceuticals Granted Unique J-Code for Byfavo®¹ (remimazolam for injection) from CMS
|
|
Apr 27
|
Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023
|